Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene

American Journal of Hypertension

Volumn 9, Issue 8 I, 1996, Pages 795-802

  Stasch, Johannes Peter ^a   Hirth Dietrich, Claudia ^a   Ganten, Detlev ^b   Wegner, Max ^a  

^a BAYER AG   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Atrial natriuretic peptide; Brain natriuretic peptide; Cyclic GMP; Ecadotril; Hypertension; Neutral endopeptidase (enkephalinase) inhibition; Sinorphan; Transgenic TGR(m(Ren2)27) rats

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; ENZYME INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; RENIN; SINORPHAN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; HEART WEIGHT; HYPERTENSION; KIDNEY MASS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; TRANSGENIC ANIMAL;

EID: 0029741665     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(96)00099-4     Document Type: Article

References (30)

1. Ruskoaho H: Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 1992;44:479-602.
2. Norman JA, Little D, Bolgar M, Di Donato G: Degradation of brain natriuretic peptide by neutral endopeptidase: species specific sites of proteolysis determined by mass spectrometry. Biochem Biophys Res Commun 1991;175:22-30.
3. Erdös EG, Skidgel RA: Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 1989;3:145-151.
4. Wilkins MR, Unwin RJ, Kenny AJ: Endopeptidase-24.11 and its inhibitors: potential therapeutic agents for edematous disorders and hypertension. Kidney Int 1993;43:273-285.
5. Morita E, Yasue H, Yoshimura M, et al: Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993; 88:82-91.
6. Dussaule JC, Michel C, Peraldi MN, et al: Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure. Clin Sci 1993; 84:31-39.
7. Lefrancois P, Clerc G, Duchier J, et al: Antihypertensive activity of sinorphan. Lancet 1990;336:307-308.
8. Kahn JC, Patey M, Dubois-Rande JL, et al: Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure. Lancet 1990;335:118-119.
9. Lang CC, Motwani JJ Coutie WJR, Struthers AD. Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism. Clin Sci 1992;82:619-623.
10. Hirata Y, Suzuki Y, Suzuki E, et al: Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors. J Hypertens 1994;12:367-374.
11. Hirth-Dietrich C, Stasch JP, Ganten D, Luft FC: Renal effects of captopril and nitrendipine in transgenic rats with an extra renin gene. Hypertension 1994;23:626-631.
12. Mullins JJ, Peters J, Ganten D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2-gene. Nature 1990;344:541-544.
13. Hirth-Dietrich C, Kick R, Stasch JP, et al: Enhanced natriuresis in transgenic rats with a mouse renin gene (TGR(mRen2)27) (abst). J Hypertens 1992;10(suppl 4):122.
14. Wegner M, Stasch JP, Hirth-Dietrich C, et al: Interaction of a neutral endopeptidase inhibitor with an ANP C receptor ligand in anaesthetized dogs. Clin Exp Hypertens [A] 1995;17:861-876.
15. Stasch JP, Knorr A, Wegner M, Hirth-Dietrich C: Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in SHR-SP. Hypertens Res 1995;18:137-143.
16. Gutman I, Bergmeyer HU: Bestimmung von Harnstoff, Glutamat-Dehydrogenase als Indikatorenzym, in Bergmeyer HU (ed): Methoden der enymatischen Analyse, 3rd ed., Vol. II (in German). Verlag Chemie, Weinheim, Germany, 1974, pp 1842-1846.
17. Town M-H, Gehm S, Hammer B, Ziegenhorn J: A sensitive colorimetric method for the enzymatic determination of uric acid. J Clin Chem Clin Biochem 1985; 23:591-599.
18. Luft FC, Grim CE, Willis LR, et al: Natriuretic response to saline infusion in normotensive and hypertensive man: the role of renin suppression in exaggerated natriuresis. Circulation 1977;55:779-784.
19. Jin H, Mathews C, Chen YF, et al: Effects of acute and chronic blockade of neutral endopeptidase with SCH 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats. Am J Hypertens 1992;5:210-218.
20. Seymour AA, Norman JA, Asaad MM, et al: Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11. and clearance receptors. J Pharmacol Exp Ther 1991;256:1002-1009.
21. Koepke JP, Tyler LD, Trapani AJ, et al: Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats. J Pharmacol Exp Ther 1989;249:172-176.
22. Koepke JP, Tylor LD, Mehta PP, et al: Atriopeptin regulation and renal function in conscious spontaneously hypertensive rats. Am J Hypertens 1990;3:622-627.
23. Mukoyama M, Nakao K, Saito Y, et al: Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans. J Clin Invest 1991;87:1402-1412.
24. Schmitt F, Martinez F, Ikeni A, et al: Acute renal effects of neutral endopeptidase inhibition in humans. Am J Physiol 1994;267:F20-F27.
25. Lecomte JM, Baumer P, Lim C, et al: Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans. Eur J Pharmacol 1990;179:65-73.
26. Dussaule JC, Stefanski A, Bea ML, et al: Characterization of neutral endopeptidase in vascular smooth muscle cells of rabbit renal cortex. Am J Physiol 1983; 264:F45-F52.
27. Hirata Y, Suzuki E, Hayakawa H, et al: Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats. J Cardiovasc Pharmacol 1994;23:283-290.
28. Sybertz EJ, Chiu PJS, Vemulapalli S, et al: SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats. J Pharmacol Exp Ther 1989; 250:624-631.
29. Mukoyama M, Nakao K, Saito Y, et al: Human brain natriuretic peptide, a novel cardiac hormone. Lancet 1990;335:801-802.
30. Monopoli A, Ongini E, Cigola E, Olivetti G: The neutral endopeptidase inhibitor, SCH 34826, reduces left ventricular hypertrophy in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1993;20:496-504.